日本新薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2025/12/04 | 4,323 | 4,323 | 4,323 | 4,323 | +700 | +19.3% | 191,500 |
| 2025/12/03 | 3,598 | 3,642 | 3,580 | 3,623 | -19 | -0.5% | 367,700 |
| 2025/12/02 | 3,542 | 3,642 | 3,530 | 3,642 | +89 | +2.5% | 551,500 |
| 2025/12/01 | 3,600 | 3,617 | 3,522 | 3,553 | -80 | -2.2% | 795,600 |
| 2025/11/28 | 3,642 | 3,667 | 3,624 | 3,633 | -15 | -0.4% | 284,800 |
| 2025/11/27 | 3,660 | 3,708 | 3,635 | 3,648 | -53 | -1.4% | 153,800 |
| 2025/11/26 | 3,614 | 3,701 | 3,602 | 3,701 | +99 | +2.7% | 328,900 |
| 2025/11/25 | 3,620 | 3,632 | 3,583 | 3,602 | -25 | -0.7% | 293,600 |
| 2025/11/21 | 3,603 | 3,643 | 3,603 | 3,627 | +3 | +0.1% | 574,500 |
| 2025/11/20 | 3,600 | 3,644 | 3,600 | 3,624 | +4 | +0.1% | 301,600 |
| 2025/11/19 | 3,530 | 3,659 | 3,530 | 3,620 | +95 | +2.7% | 547,300 |
| 2025/11/18 | 3,552 | 3,635 | 3,508 | 3,525 | -21 | -0.6% | 328,500 |
| 2025/11/17 | 3,558 | 3,572 | 3,477 | 3,546 | -8 | -0.2% | 372,200 |
| 2025/11/14 | 3,361 | 3,637 | 3,332 | 3,554 | +197 | +5.9% | 674,300 |
| 2025/11/13 | 3,364 | 3,400 | 3,354 | 3,357 | +17 | +0.5% | 225,000 |
| 2025/11/12 | 3,327 | 3,364 | 3,316 | 3,340 | +36 | +1.1% | 182,800 |
| 2025/11/11 | 3,275 | 3,308 | 3,263 | 3,304 | +43 | +1.3% | 213,400 |
| 2025/11/10 | 3,290 | 3,290 | 3,261 | 3,261 | -18 | -0.5% | 168,500 |
| 2025/11/07 | 3,251 | 3,286 | 3,247 | 3,279 | +52 | +1.6% | 185,800 |
| 2025/11/06 | 3,245 | 3,258 | 3,227 | 3,227 | -21 | -0.6% | 170,400 |
| 2025/11/05 | 3,270 | 3,290 | 3,203 | 3,248 | -22 | -0.7% | 214,500 |
| 2025/11/04 | 3,252 | 3,282 | 3,219 | 3,270 | +49 | +1.5% | 293,700 |
| 2025/10/31 | 3,272 | 3,277 | 3,221 | 3,221 | -50 | -1.5% | 272,200 |
| 2025/10/30 | 3,210 | 3,276 | 3,205 | 3,271 | +54 | +1.7% | 415,400 |
| 2025/10/29 | 3,300 | 3,306 | 3,212 | 3,217 | -96 | -2.9% | 261,700 |
| 2025/10/28 | 3,325 | 3,333 | 3,292 | 3,313 | -23 | -0.7% | 174,000 |
| 2025/10/27 | 3,349 | 3,363 | 3,327 | 3,336 | +15 | +0.5% | 199,100 |
| 2025/10/24 | 3,362 | 3,370 | 3,318 | 3,321 | -61 | -1.8% | 124,700 |
| 2025/10/23 | 3,388 | 3,414 | 3,363 | 3,382 | +13 | +0.4% | 324,300 |
| 2025/10/22 | 3,318 | 3,380 | 3,318 | 3,369 | +78 | +2.4% | 380,700 |
| 2025/10/21 | 3,286 | 3,305 | 3,285 | 3,291 | +1 | ±0% | 105,300 |
| 2025/10/20 | 3,300 | 3,316 | 3,282 | 3,290 | +41 | +1.3% | 203,300 |
| 2025/10/17 | 3,258 | 3,263 | 3,241 | 3,249 | -9 | -0.3% | 127,500 |
| 2025/10/16 | 3,262 | 3,270 | 3,247 | 3,258 | +12 | +0.4% | 102,400 |
| 2025/10/15 | 3,244 | 3,256 | 3,225 | 3,246 | +33 | +1% | 179,300 |
| 2025/10/14 | 3,220 | 3,253 | 3,187 | 3,213 | -71 | -2.2% | 465,300 |
| 2025/10/10 | 3,346 | 3,352 | 3,284 | 3,284 | -103 | -3% | 239,200 |
| 2025/10/09 | 3,305 | 3,387 | 3,300 | 3,387 | +73 | +2.2% | 318,200 |
| 2025/10/08 | 3,316 | 3,341 | 3,307 | 3,314 | -2 | -0.1% | 186,000 |
| 2025/10/07 | 3,310 | 3,345 | 3,297 | 3,316 | -14 | -0.4% | 233,800 |
| 2025/10/06 | 3,330 | 3,365 | 3,311 | 3,330 | +34 | +1% | 336,700 |
| 2025/10/03 | 3,300 | 3,314 | 3,285 | 3,296 | +3 | +0.1% | 289,600 |
| 2025/10/02 | 3,290 | 3,305 | 3,240 | 3,293 | +31 | +1% | 221,100 |
| 2025/10/01 | 3,333 | 3,342 | 3,262 | 3,262 | -71 | -2.1% | 285,300 |
| 2025/09/30 | 3,270 | 3,339 | 3,265 | 3,333 | +68 | +2.1% | 344,500 |
| 2025/09/29 | 3,319 | 3,320 | 3,262 | 3,265 | -102 | -3% | 315,300 |
| 2025/09/26 | 3,339 | 3,409 | 3,320 | 3,367 | +58 | +1.8% | 497,300 |
| 2025/09/25 | 3,320 | 3,328 | 3,303 | 3,309 | -5 | -0.2% | 262,400 |
| 2025/09/24 | 3,340 | 3,340 | 3,306 | 3,314 | -5 | -0.2% | 320,000 |
| 2025/09/22 | 3,329 | 3,332 | 3,302 | 3,319 | -23 | -0.7% | 277,900 |
101～
150
件表示中 / 3937件
類似銘柄と比較する
現在ご覧いただいている「日本新薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 日本新薬 | 409,300円 | +6.1% | -6.7% | 3.03% | 10.49倍 | 1.06倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
| 参天薬 | 161,750円 | -2.0% | -7.3% | 2.35% | 15.30倍 | 1.89倍 |
|
緑内障、加齢黄斑変性、ドライアイ治療薬など眼科用医薬品首位。一般用目薬「サンテ」が有名 |
| 久光薬 | 604,000円 | - | - | - | - | 1.46倍 |
|
貼る鎮痛消炎剤首位。医療用シェア５割。大衆薬「サロンパス」で有名。ＭＢＯで上場廃止へ |
| ツムラ | 358,200円 | +9.3% | -18.7% | 4.02% | 10.99倍 | 0.91倍 |
|
医療用漢方薬で国内シェア８割超。高齢者、がん支持療法、女性関連の３領域を重点に市場深耕 |
| サワイＧＨＤ | 210,200円 | +7.1% | +526.4% | 2.62% | 17.34倍 | 1.37倍 |
|
後発医薬品大手で、幅広い取り扱い品目。２１年に沢井製薬が持株会社化。安定供給へ生産増強中 |
市場注目の銘柄
チャート関連のコラム
